Not Medicare Enrolled

Dr. Deena Gandhi, MD

Psychiatry · Sugar Land, TX
56 SUGAR CREEK CENTER BLVD, Sugar Land, TX 77478
2812779137
Registered in NPPES since 2005
NPI: 1124021480 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 2 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Gandhi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gandhi? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Gandhi

Dr. Deena Gandhi is a psychiatry specialist in Sugar Land, TX, with 21 years of NPI registration.

Between the years covered by Open Payments, Dr. Gandhi received a total of $92,542 from 53 pharmaceutical and/or device companies across 1467 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Gandhi is Moderate — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 21 years of NPI registration $92,542 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$92,542
Total received (2018-2024)
Avg $13,220/year across 7 years
Top 2% in TX for psychiatry
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
53
Companies
1,467
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$22,898
2023
$26,884
2022
$26,401
2021
$4,698
2020
$3,091
2019
$4,583
2018
$3,988

Payments by company (2024)

Supernus Pharmaceuticals, Inc.
$17,373
ABBVIE INC.
$771
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$749
Janssen Pharmaceuticals, Inc
$520
Axsome Therapeutics, Inc.
$472
Otsuka America Pharmaceutical, Inc.
$437
Lundbeck LLC
$261
Corium, LLC
$255
Takeda Pharmaceuticals U.S.A., Inc.
$228
Tris Pharma Inc
$225
Teva Pharmaceuticals USA, Inc.
$220
Alkermes, Inc.
$208
Almatica Pharma LLC
$177
Bausch Health US, LLC
$173
IDORSIA PHARMACEUTICALS US INC
$172
Vanda Pharmaceuticals Inc.
$170
IRONSHORE PHARMACEUTICALS INC.
$140
JAZZ PHARMACEUTICALS INC.
$122
Pulmonx Corporation
$92
Neurocrine Biosciences, Inc.
$61
Vertical Pharmaceuticals, LLC
$39
Noven Therapeutics, LLC
$17
Neos Therapeutics, LP
$16
Top 3 companies account for 82.5% of 2024 payments
All-time payments by company (2018-2024) ›
Supernus Pharmaceuticals, Inc.
$62,325
Otsuka America Pharmaceutical, Inc.
$2,990
Janssen Pharmaceuticals, Inc
$2,312
Sunovion Pharmaceuticals Inc.
$2,104
ABBVIE INC.
$1,999
Bausch Health US, LLC
$1,967
Takeda Pharmaceuticals U.S.A., Inc.
$1,922
ITI, Inc.
$1,529
Neos Therapeutics, LP
$1,300
Lundbeck LLC
$1,188
Corium, LLC
$1,146
Teva Pharmaceuticals USA, Inc.
$1,042
Allergan Inc.
$934
Axsome Therapeutics, Inc.
$913
Ironshore Pharmaceuticals Inc.
$911
Alkermes, Inc.
$785
Vanda Pharmaceuticals Inc.
$782
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$749
Tris Pharma Inc
$628
JAZZ PHARMACEUTICALS INC.
$492
Shire North American Group Inc
$412
Allergan, Inc.
$405
AbbVie Inc.
$398
Almatica Pharma LLC
$296
Noven Therapeutics, LLC
$263
Indivior Inc.
$244
Jazz Pharmaceuticals Inc.
$242
Eisai Inc.
$224
Neurocrine Biosciences, Inc.
$215
Orexo US, Inc.
$205
IDORSIA PHARMACEUTICALS US INC
$204
IRONSHORE PHARMACEUTICALS INC.
$140
ARBOR PHARMACEUTICALS, INC.
$123
Adlon Therapeutics L.P.
$120
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$119
Vertical Pharmaceuticals, LLC
$117
Pulmonx Corporation
$92
Impulse Dynamics (USA) Inc.
$87
Corium, Inc.
$82
Avanir Pharmaceuticals, Inc.
$73
EISAI INC.
$72
LivaNova USA, Inc.
$59
Rhodes Pharmaceuticals L.P.
$59
Abbott Laboratories
$57
Neuronetics, Inc.
$54
Noven Pharmaceuticals, Inc.
$52
ACADIA Pharmaceuticals Inc
$22
Alfasigma USA, Inc.
$16
Validus Pharmaceuticals LLC
$16
Merck Sharp & Dohme Corporation
$15
US WorldMeds, LLC
$15
Arbor Pharmaceuticals, Inc.
$15
Brainsway USA Inc
$11
Top 3 companies account for 73.1% of all-time payments
Associated products mentioned in payments ›
ABILIFY MAINTENA · ABILIFY MYCITE · ADHANSIA XR · APLENZIN · ARISTADA · AUSTEDO · AZSTARYS · Adzenys XR-ODT · Aptensio XR · Austedo XR · Auvelity · Azstarys · BELSOMRA · BRINTELLIX · Brainsway Deep TMS · CAPLYTA · CHARTIS CATHETER · COTEMPLA XR-ODT · CardioMEMS HF System · Cotempla XR-ODT · Dayvigo · Dyanavel XR · Edarbi · Equetro · Evekeo · Evekeo ODT · FANAPT · Fanapt · HETLIOZ · Horizant · INGREZZA · INVEGA · INVEGA SUSTENNA · INVEGA TRINZA · JORNAY PM · Jornay PM 20mg capsules (Bottle of 100) · LATUDA · LOREEV XR · LYBALVI · LifeVest · Lucemyra/Lofexidine · METHYLPHENIDATE 72 · MYDAYIS · NEUROSTAR TMS THERAPY · NUEDEXTA · NUPLAZID · Optimizer Smart System · PERSERIS · QELBREE · QUVIVIQ · Qelbree · Quillichew ER · RELEXXII · REXULTI · Relexxii · SECUADO · SPRAVATO · SUBLOCADE · SUNOSI · Secuado · Sunosi · TRINTELLIX · Trintellix · VIIBRYD · VNS Therapy · VRAYLAR · VYVANSE · WELLBUTRIN · WELLBUTRIN XL · XARELTO · XYREM · XYWAV · Xelstrym · Zubsolv
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a psychiatry specialist in Sugar Land?
Compare psychiatrists in the Sugar Land area by procedure volume, costs, and industry payment transparency.
Browse psychiatrists nearby

Geographic Context

Psychiatrists in nearby ZIP areas
713
County median income
$113,409
Nearest hospital to ZIP centroid (approximate)
ST LUKE'S SUGAR LAND HOSPITAL
0.0 mi

Data Sources

Provider Registry ✓ NPPES NPPES snapshot; verify current record
Medicare Enrollment — Not enrolled N/A
Practice Data — No data N/A
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 2 of 4 available federal datasets, with a Data Coverage level of Moderate. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Gandhi is a psychiatry specialist, with 21 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Gandhi receive payments from pharmaceutical companies?
Yes. Dr. Gandhi received a total of $92,542 from 53 companies across 1,467 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Dr. Gandhi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →

Explore related providers

Same specialty & city
Psychiatrists in Sugar Land
Browse psychiatrists in Sugar Land ranked by procedure volume and transparency data.
Highest volume
Top Psychiatrists in TX
Psychiatrists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Psychiatrists in TX
Which TX psychiatrists receive the most from drug and device companies.
By company
Supernus Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Supernus Pharmaceuticals, Inc.
By company
Otsuka America Pharmaceutical, Inc. Payments to Doctors
See all physicians who received payments from Otsuka America Pharmaceutical, Inc.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →